메뉴 건너뛰기




Volumn 82, Issue SUPPL. 2, 2008, Pages

Can geneticists help clinicians to understand and treat non-autoimmune diabetes?

Author keywords

MODY; Monogenic diabetes; Neonatal diabetes; Pharmacogenetics; Sulphonylurea

Indexed keywords

GLICLAZIDE; INSULIN; METFORMIN; SULFONYLUREA;

EID: 56949091074     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.020     Document Type: Article
Times cited : (6)

References (117)
  • 1
    • 0033870207 scopus 로고    scopus 로고
    • Unravelling the heterogeneity of non insulin dependent diabetes
    • Pearson E.R., and Hattersley A.T. Unravelling the heterogeneity of non insulin dependent diabetes. J. R. Coll. Physicians Lond. 34 (2000) 332-335
    • (2000) J. R. Coll. Physicians Lond. , vol.34 , pp. 332-335
    • Pearson, E.R.1    Hattersley, A.T.2
  • 2
    • 27144453762 scopus 로고    scopus 로고
    • Molecular genetics goes to the diabetes clinic
    • Hattersley A.T. Molecular genetics goes to the diabetes clinic. Clin. Med. 5 (2005) 476-481
    • (2005) Clin. Med. , vol.5 , pp. 476-481
    • Hattersley, A.T.1
  • 3
    • 0035557623 scopus 로고    scopus 로고
    • Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes
    • McCarthy M.I., and Hattersley A.T. Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev. Mol. Diagn. 1 (2001) 403-412
    • (2001) Expert Rev. Mol. Diagn. , vol.1 , pp. 403-412
    • McCarthy, M.I.1    Hattersley, A.T.2
  • 4
    • 0031914679 scopus 로고    scopus 로고
    • Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity
    • Hattersley A.T. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet. Med. 15 (1998) 15-24
    • (1998) Diabet. Med. , vol.15 , pp. 15-24
    • Hattersley, A.T.1
  • 5
    • 0016244025 scopus 로고
    • Mild familial diabetes with dominant inheritance
    • Tattersall R.B. Mild familial diabetes with dominant inheritance. Q. J. Med. 43 (1974) 339-357
    • (1974) Q. J. Med. , vol.43 , pp. 339-357
    • Tattersall, R.B.1
  • 6
    • 0031892442 scopus 로고    scopus 로고
    • Maturity-onset diabetes of the young: a clinical history
    • Tattersall R.B. Maturity-onset diabetes of the young: a clinical history. Diabet. Med. 15 (1998) 11-14
    • (1998) Diabet. Med. , vol.15 , pp. 11-14
    • Tattersall, R.B.1
  • 7
    • 0035960122 scopus 로고    scopus 로고
    • Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
    • Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 (2001) 971-980
    • (2001) N. Engl. J. Med. , vol.345 , pp. 971-980
    • Fajans, S.S.1    Bell, G.I.2    Polonsky, K.S.3
  • 8
    • 0028087153 scopus 로고
    • Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree
    • Herman W.H., Fajans S.S., Ortiz F.J., Smith M.J., Sturis J., Bell G.I., et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43 (1994) 40-46
    • (1994) Diabetes , vol.43 , pp. 40-46
    • Herman, W.H.1    Fajans, S.S.2    Ortiz, F.J.3    Smith, M.J.4    Sturis, J.5    Bell, G.I.6
  • 9
    • 0025854216 scopus 로고
    • Maturity onset-type diabetes of the young (MODY): one condition or many?
    • Tattersall R.B., and Mansell P.I. Maturity onset-type diabetes of the young (MODY): one condition or many?. Diabet. Med. 8 (1991) 402-410
    • (1991) Diabet. Med. , vol.8 , pp. 402-410
    • Tattersall, R.B.1    Mansell, P.I.2
  • 10
    • 0026562918 scopus 로고
    • Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
    • Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G.I., Zouali H., et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356 (1992) 721-722
    • (1992) Nature , vol.356 , pp. 721-722
    • Vionnet, N.1    Stoffel, M.2    Takeda, J.3    Yasuda, K.4    Bell, G.I.5    Zouali, H.6
  • 11
    • 10544236911 scopus 로고    scopus 로고
    • Mutations in the hepatocyte nuclear factor-4α gene in the maturity-onset diabetes of the young (MODY1)
    • Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., et al. Mutations in the hepatocyte nuclear factor-4α gene in the maturity-onset diabetes of the young (MODY1). Nature 384 (1996) 458-460
    • (1996) Nature , vol.384 , pp. 458-460
    • Yamagata, K.1    Furuta, H.2    Oda, N.3    Kaisaki, P.J.4    Menzel, S.5    Cox, N.J.6
  • 12
    • 10544249874 scopus 로고    scopus 로고
    • Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3)
    • Yamagata K., Oda N., Kaisaki P.J., Menzel S., Furuta H., Vaxillaire M., et al. Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3). Nature 384 (1996) 455-458
    • (1996) Nature , vol.384 , pp. 455-458
    • Yamagata, K.1    Oda, N.2    Kaisaki, P.J.3    Menzel, S.4    Furuta, H.5    Vaxillaire, M.6
  • 13
    • 0031253820 scopus 로고    scopus 로고
    • Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
    • Stoffers D.A., Ferrer J., Clarke W.L., and Habener J.F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17 (1997) 138-139
    • (1997) Nat. Genet. , vol.17 , pp. 138-139
    • Stoffers, D.A.1    Ferrer, J.2    Clarke, W.L.3    Habener, J.F.4
  • 14
    • 0031453186 scopus 로고    scopus 로고
    • Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY
    • Horikawa Y., Iwasaki N., Hara M., Furuta H., Hinokio Y., Cockburn B.N., et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet. 17 (1997) 384-385
    • (1997) Nat. Genet. , vol.17 , pp. 384-385
    • Horikawa, Y.1    Iwasaki, N.2    Hara, M.3    Furuta, H.4    Hinokio, Y.5    Cockburn, B.N.6
  • 15
    • 0032700272 scopus 로고    scopus 로고
    • Mutations in the NEUROD1 gene are associated with the development of type 2 diabetes mellitus
    • Malecki M.T., Jhala U.S., Antonellis A., Fields L., Doria A., Orban T., et al. Mutations in the NEUROD1 gene are associated with the development of type 2 diabetes mellitus. Nat. Genet. 23 (1999) 323-328
    • (1999) Nat. Genet. , vol.23 , pp. 323-328
    • Malecki, M.T.1    Jhala, U.S.2    Antonellis, A.3    Fields, L.4    Doria, A.5    Orban, T.6
  • 16
    • 0022538272 scopus 로고
    • Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets
    • Iynedjian P.B., Mobius G., Seitz H.J., Wollheim C.B., and Renold A.E. Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 1998-2001
    • (1986) Proc. Natl. Acad. Sci. U.S.A. , vol.83 , pp. 1998-2001
    • Iynedjian, P.B.1    Mobius, G.2    Seitz, H.J.3    Wollheim, C.B.4    Renold, A.E.5
  • 17
    • 29444440400 scopus 로고    scopus 로고
    • Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
    • Raeder H., Johansson S., Holm P.I., Haldorsen I.S., Mas E., Sbarra V., et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat. Genet. 38 (2006) 54-62
    • (2006) Nat. Genet. , vol.38 , pp. 54-62
    • Raeder, H.1    Johansson, S.2    Holm, P.I.3    Haldorsen, I.S.4    Mas, E.5    Sbarra, V.6
  • 18
    • 41149139275 scopus 로고    scopus 로고
    • Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
    • European Molecular Genetics Quality Network (EMQN) MODY group
    • Ellard S., Bellanné-Chantelot C., Hattersley A.T., and European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51 (2008) 546-553
    • (2008) Diabetologia , vol.51 , pp. 546-553
    • Ellard, S.1    Bellanné-Chantelot, C.2    Hattersley, A.T.3
  • 19
  • 20
    • 0027472126 scopus 로고
    • Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
    • Froguel P., Zouali H., Vionnet N., Velho G., Vaxillaire M., Sun F., et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328 (1993) 697-702
    • (1993) N. Engl. J. Med. , vol.328 , pp. 697-702
    • Froguel, P.1    Zouali, H.2    Vionnet, N.3    Velho, G.4    Vaxillaire, M.5    Sun, F.6
  • 21
    • 0035122350 scopus 로고    scopus 로고
    • Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations
    • Pearson E.R., Velho G., Clark P., Stride A., Shepherd M., Frayling T.M., et al. Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 50 Suppl. 1 (2001) S101-S107
    • (2001) Diabetes , vol.50 , Issue.SUPPL. 1
    • Pearson, E.R.1    Velho, G.2    Clark, P.3    Stride, A.4    Shepherd, M.5    Frayling, T.M.6
  • 22
    • 0034000635 scopus 로고    scopus 로고
    • A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
    • Ellard S., Beards F., Allen L.I., Shepherd M., Ballantyne E., Harvey R., et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43 (2000) 250-253
    • (2000) Diabetologia , vol.43 , pp. 250-253
    • Ellard, S.1    Beards, F.2    Allen, L.I.3    Shepherd, M.4    Ballantyne, E.5    Harvey, R.6
  • 23
    • 33646778478 scopus 로고    scopus 로고
    • Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes
    • Hattersley A.T., and Pearson E.R. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 147 (2006) 2657-2663
    • (2006) Endocrinology , vol.147 , pp. 2657-2663
    • Hattersley, A.T.1    Pearson, E.R.2
  • 25
    • 33646790589 scopus 로고    scopus 로고
    • Fetal growth is altered by fetal genotype and not insulin treatment of maternal hyperglycaemia in gestational diabetes due to mutations in the glucokinase gene
    • Spyer G., Ballantyne E., Shepherd M., Allen L., Macleod K., Ellard S., et al. Fetal growth is altered by fetal genotype and not insulin treatment of maternal hyperglycaemia in gestational diabetes due to mutations in the glucokinase gene. Diabet. Med. 17 Suppl. A (2000) 40
    • (2000) Diabet. Med. , vol.17 , Issue.SUPPL. A , pp. 40
    • Spyer, G.1    Ballantyne, E.2    Shepherd, M.3    Allen, L.4    Macleod, K.5    Ellard, S.6
  • 27
    • 0036200587 scopus 로고    scopus 로고
    • Liver-enriched transcription factors in liver function and development. Part I. The hepatocyte nuclear factor network and liver-specific gene expression
    • Schrem H., Klempnauer J., and Borlak J. Liver-enriched transcription factors in liver function and development. Part I. The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 54 (2002) 129-158
    • (2002) Pharmacol. Rev. , vol.54 , pp. 129-158
    • Schrem, H.1    Klempnauer, J.2    Borlak, J.3
  • 28
    • 0035512077 scopus 로고    scopus 로고
    • Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism
    • Shih D.Q., Screenan S., Munoz K.N., Philipson L., Pontoglio M., Yaniv M., et al. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50 (2001) 2472-2480
    • (2001) Diabetes , vol.50 , pp. 2472-2480
    • Shih, D.Q.1    Screenan, S.2    Munoz, K.N.3    Philipson, L.4    Pontoglio, M.5    Yaniv, M.6
  • 29
    • 0031985396 scopus 로고    scopus 로고
    • A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus
    • Habener J.F., and Stoffers D.A. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc. Assoc. Am. Physicians 110 (1998) 12-21
    • (1998) Proc. Assoc. Am. Physicians , vol.110 , pp. 12-21
    • Habener, J.F.1    Stoffers, D.A.2
  • 30
    • 0030886674 scopus 로고    scopus 로고
    • Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice
    • Naya F.J., Huang H.P., Qiu Y., Mutoh H., DeMayo F.J., Leiter A.B., et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11 (1997) 2323-2334
    • (1997) Genes Dev. , vol.11 , pp. 2323-2334
    • Naya, F.J.1    Huang, H.P.2    Qiu, Y.3    Mutoh, H.4    DeMayo, F.J.5    Leiter, A.B.6
  • 31
    • 0035122282 scopus 로고    scopus 로고
    • Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors
    • Frayling T.M., Evans J.C., Bulman M.P., Pearson E., Allen L., Owen K., et al. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 Suppl. 1 (2001) S94-S100
    • (2001) Diabetes , vol.50 , Issue.SUPPL. 1
    • Frayling, T.M.1    Evans, J.C.2    Bulman, M.P.3    Pearson, E.4    Allen, L.5    Owen, K.6
  • 34
    • 0033847575 scopus 로고    scopus 로고
    • Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes
    • Pearson E.R., Liddell W.G., Shepherd M., Corrall R.J., and Hattersley A.T. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet. Med. 17 (2000) 543-545
    • (2000) Diabet. Med. , vol.17 , pp. 543-545
    • Pearson, E.R.1    Liddell, W.G.2    Shepherd, M.3    Corrall, R.J.4    Hattersley, A.T.5
  • 36
    • 0042071600 scopus 로고    scopus 로고
    • Sulphonylurea action revisited: the post-cloning era
    • Gribble F.M., and Reimann F. Sulphonylurea action revisited: the post-cloning era. Diabetologia 46 (2003) 875-891
    • (2003) Diabetologia , vol.46 , pp. 875-891
    • Gribble, F.M.1    Reimann, F.2
  • 37
    • 0031684710 scopus 로고    scopus 로고
    • A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene
    • Menzel R., Kaisaki P.J., Rjasanowski I., Heinke P., Kerner W., and Menzel S. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet. Med. 15 (1998) 816-820
    • (1998) Diabet. Med. , vol.15 , pp. 816-820
    • Menzel, R.1    Kaisaki, P.J.2    Rjasanowski, I.3    Heinke, P.4    Kerner, W.5    Menzel, S.6
  • 39
    • 21544451980 scopus 로고    scopus 로고
    • Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers
    • Stride A., Ellard S., Clark P., Shakespeare L., Salzmann M., Shepherd M., et al. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 28 (2005) 1751-1756
    • (2005) Diabetes Care , vol.28 , pp. 1751-1756
    • Stride, A.1    Ellard, S.2    Clark, P.3    Shakespeare, L.4    Salzmann, M.5    Shepherd, M.6
  • 40
    • 49649099316 scopus 로고    scopus 로고
    • Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young
    • Skupien J., Gorczynska-Kosiorz S., Klupa T., Wanic K., Button E.A., Sieradzki J., et al. Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young. Diabetes Care 31 (2008) 1496-1501
    • (2008) Diabetes Care , vol.31 , pp. 1496-1501
    • Skupien, J.1    Gorczynska-Kosiorz, S.2    Klupa, T.3    Wanic, K.4    Button, E.A.5    Sieradzki, J.6
  • 41
    • 33644813829 scopus 로고    scopus 로고
    • Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1alpha (MODY3) gene
    • Malecki M.T., Skupien J., Gorczynska-Kosiorz S., Klupa T., Nazim J., Moczulski D.K., et al. Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1alpha (MODY3) gene. Diabetes Care 28 (2005) 2774-2776
    • (2005) Diabetes Care , vol.28 , pp. 2774-2776
    • Malecki, M.T.1    Skupien, J.2    Gorczynska-Kosiorz, S.3    Klupa, T.4    Nazim, J.5    Moczulski, D.K.6
  • 42
    • 20044396943 scopus 로고    scopus 로고
    • Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection
    • Pearson E.R., Pruhova S., Tack C.J., Johansen A., Castleden H.A., Lumb P.J., et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 48 (2005) 878-885
    • (2005) Diabetologia , vol.48 , pp. 878-885
    • Pearson, E.R.1    Pruhova, S.2    Tack, C.J.3    Johansen, A.4    Castleden, H.A.5    Lumb, P.J.6
  • 43
    • 35848955882 scopus 로고    scopus 로고
    • Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A)
    • Fajans S.S., and Bell G.I. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A). Diabetologia 50 (2007) 2600-2601
    • (2007) Diabetologia , vol.50 , pp. 2600-2601
    • Fajans, S.S.1    Bell, G.I.2
  • 44
    • 34247500820 scopus 로고    scopus 로고
    • Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene
    • Pearson E.R., Boj S.F., Steele A.M., Barrett T., Stals K., Shield J.P., et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 4 (2007) e118
    • (2007) PLoS Med. , vol.4
    • Pearson, E.R.1    Boj, S.F.2    Steele, A.M.3    Barrett, T.4    Stals, K.5    Shield, J.P.6
  • 45
    • 0034035239 scopus 로고    scopus 로고
    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
    • Shih D.Q., Dansky H.M., Fleisher M., Assmann G., Fajans S.S., Stoffel M., et al. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 49 (2000) 832-837
    • (2000) Diabetes , vol.49 , pp. 832-837
    • Shih, D.Q.1    Dansky, H.M.2    Fleisher, M.3    Assmann, G.4    Fajans, S.S.5    Stoffel, M.6
  • 46
    • 0036227445 scopus 로고    scopus 로고
    • Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations
    • Bingham C., Ellard S., Cole T.R., Jones K.E., Allen L.I., Goodship J.A., et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations. Kidney Int. 61 (2002) 1243-1251
    • (2002) Kidney Int. , vol.61 , pp. 1243-1251
    • Bingham, C.1    Ellard, S.2    Cole, T.R.3    Jones, K.E.4    Allen, L.I.5    Goodship, J.A.6
  • 47
    • 0036329071 scopus 로고    scopus 로고
    • Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement
    • Montoli A., Colussi G., Massa O., Caccia R., Rizzoni G., Civati G., et al. Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement. Am. J. Kidney Dis. 40 (2002) 397-402
    • (2002) Am. J. Kidney Dis. , vol.40 , pp. 397-402
    • Montoli, A.1    Colussi, G.2    Massa, O.3    Caccia, R.4    Rizzoni, G.5    Civati, G.6
  • 48
    • 2342472176 scopus 로고    scopus 로고
    • Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations
    • Pearson E.R., Badman M.K., Lockwood C.R., Clark P.M., Ellard S., Bingham C., et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care 27 (2004) 1102-1107
    • (2004) Diabetes Care , vol.27 , pp. 1102-1107
    • Pearson, E.R.1    Badman, M.K.2    Lockwood, C.R.3    Clark, P.M.4    Ellard, S.5    Bingham, C.6
  • 50
    • 38949096076 scopus 로고    scopus 로고
    • Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3
    • Vesterhus M., Raeder H., Johansson S., Molven A., and Njølstad P.R. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3. Diabetes Care 31 (2008) 306-310
    • (2008) Diabetes Care , vol.31 , pp. 306-310
    • Vesterhus, M.1    Raeder, H.2    Johansson, S.3    Molven, A.4    Njølstad, P.R.5
  • 52
    • 0022356341 scopus 로고
    • The insulin-pancreatic acinar axis
    • Williams J.A., and Golfie I.D. The insulin-pancreatic acinar axis. Diabetes 34 (1985) 980-986
    • (1985) Diabetes , vol.34 , pp. 980-986
    • Williams, J.A.1    Golfie, I.D.2
  • 53
    • 33644776570 scopus 로고    scopus 로고
    • Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations
    • Brackenridge A., Pearson E.R., Shojaee-Moradie F., Hattersley A.T., Russell-Jones D., and Umpleby A.M. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations. Diabetes 55 (2006) 405-411
    • (2006) Diabetes , vol.55 , pp. 405-411
    • Brackenridge, A.1    Pearson, E.R.2    Shojaee-Moradie, F.3    Hattersley, A.T.4    Russell-Jones, D.5    Umpleby, A.M.6
  • 54
    • 0026849690 scopus 로고
    • Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion
    • Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A., Koontz D.A., et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet. 1 (1992) 11-15
    • (1992) Nat. Genet. , vol.1 , pp. 11-15
    • Ballinger, S.W.1    Shoffner, J.M.2    Hedaya, E.V.3    Trounce, I.4    Polak, M.A.5    Koontz, D.A.6
  • 55
    • 0028328317 scopus 로고
    • A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA
    • Kadowaki T., Kadowaki H., Mori Y., Tobe K., Sakuta R., Suzuki Y., et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N. Engl. J. Med. 330 (1994) 962-968
    • (1994) N. Engl. J. Med. , vol.330 , pp. 962-968
    • Kadowaki, T.1    Kadowaki, H.2    Mori, Y.3    Tobe, K.4    Sakuta, R.5    Suzuki, Y.6
  • 56
    • 0029914927 scopus 로고    scopus 로고
    • Maternally inherited diabetes and deafness: a new diabetes subtype
    • Maassen J.A., and Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 39 (1996) 375-382
    • (1996) Diabetologia , vol.39 , pp. 375-382
    • Maassen, J.A.1    Kadowaki, T.2
  • 58
    • 0027996170 scopus 로고
    • Prevalence of maternally inherited diabetes and deafness in diabetic populations in The Netherlands
    • 't Hart L.M., Lemkes H.H., Heine R.J., Stolk R.P., Feskens E.J., Jansen J.J., et al. Prevalence of maternally inherited diabetes and deafness in diabetic populations in The Netherlands. Diabetologia 37 (1994) 1169-1170
    • (1994) Diabetologia , vol.37 , pp. 1169-1170
    • 't Hart, L.M.1    Lemkes, H.H.2    Heine, R.J.3    Stolk, R.P.4    Feskens, E.J.5    Jansen, J.J.6
  • 59
    • 41749086664 scopus 로고    scopus 로고
    • Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation
    • Murphy R., Turnbull D.M., Walker M., and Hattersley A.T. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet. Med. 25 (2008) 383-399
    • (2008) Diabet. Med. , vol.25 , pp. 383-399
    • Murphy, R.1    Turnbull, D.M.2    Walker, M.3    Hattersley, A.T.4
  • 60
    • 1642422307 scopus 로고    scopus 로고
    • Decrease of beta-cells and increase of alpha-cells in a diabetic patient with mitochondrial DNA 3243 (A→G) mutation
    • Kojima T., Yamamoto M., Furuhashi N., Sarui H., Takatsu H., Takeda N., et al. Decrease of beta-cells and increase of alpha-cells in a diabetic patient with mitochondrial DNA 3243 (A→G) mutation. Intern. Med. 42 (2003) 1193-1196
    • (2003) Intern. Med. , vol.42 , pp. 1193-1196
    • Kojima, T.1    Yamamoto, M.2    Furuhashi, N.3    Sarui, H.4    Takatsu, H.5    Takeda, N.6
  • 61
    • 33845496532 scopus 로고    scopus 로고
    • Maternally inherited diabetes and deafness in a North American kindred: tips for making the diagnosis and review of unique management issues
    • Donovan L.E., and Severin N.E. Maternally inherited diabetes and deafness in a North American kindred: tips for making the diagnosis and review of unique management issues. J. Clin. Endocrinol. Metab. 91 (2006) 4737-4742
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 4737-4742
    • Donovan, L.E.1    Severin, N.E.2
  • 62
    • 85056067838 scopus 로고    scopus 로고
    • Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues
    • Malecki M.T., Skupien J., Klupa T., Naskalska A., Gorczynska-Kosiorz S., Moczulski D.K., et al. Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues. Rev. Diabet. Stud. 3 (2006) 205-207
    • (2006) Rev. Diabet. Stud. , vol.3 , pp. 205-207
    • Malecki, M.T.1    Skupien, J.2    Klupa, T.3    Naskalska, A.4    Gorczynska-Kosiorz, S.5    Moczulski, D.K.6
  • 64
    • 0031031571 scopus 로고    scopus 로고
    • Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence
    • Stoffers D.A., Zinkin N.T., Stanojevic V., Clarke W.L., and Habener J.F. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15 (1997) 106-110
    • (1997) Nat. Genet. , vol.15 , pp. 106-110
    • Stoffers, D.A.1    Zinkin, N.T.2    Stanojevic, V.3    Clarke, W.L.4    Habener, J.F.5
  • 65
    • 0034425698 scopus 로고    scopus 로고
    • EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome
    • Delepine M., Nicolino M., Barrett T., Golamaully M., Lathrop G.M., Julier C., et al. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat. Genet. 25 (2000) 406-409
    • (2000) Nat. Genet. , vol.25 , pp. 406-409
    • Delepine, M.1    Nicolino, M.2    Barrett, T.3    Golamaully, M.4    Lathrop, G.M.5    Julier, C.6
  • 66
    • 0035163909 scopus 로고    scopus 로고
    • X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
    • Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27 (2001) 18-20
    • (2001) Nat. Genet. , vol.27 , pp. 18-20
    • Wildin, R.S.1    Ramsdell, F.2    Peake, J.3    Faravelli, F.4    Casanova, J.L.5    Buist, N.6
  • 67
    • 2342633204 scopus 로고    scopus 로고
    • Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
    • Gloyn A.L., Pearson E.R., Antcliff J.F., Proks P., Bruining G.J., Slingerland A.S., et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350 (2004) 1838-1849
    • (2004) N. Engl. J. Med. , vol.350 , pp. 1838-1849
    • Gloyn, A.L.1    Pearson, E.R.2    Antcliff, J.F.3    Proks, P.4    Bruining, G.J.5    Slingerland, A.S.6
  • 69
    • 10644233000 scopus 로고    scopus 로고
    • Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features
    • Proks P., Antcliff J.F., Lippiat J., Gloyn A.L., Hattersley A.T., and Ashcroft F.M. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17539-17544
    • (2004) Proc. Natl. Acad. Sci. U.S.A. , vol.101 , pp. 17539-17544
    • Proks, P.1    Antcliff, J.F.2    Lippiat, J.3    Gloyn, A.L.4    Hattersley, A.T.5    Ashcroft, F.M.6
  • 70
    • 4644260056 scopus 로고    scopus 로고
    • Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy
    • Sagen J.V., Raeder H., Hathout E., Shehadeh N., Gudmundsson K., Baevre H., et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53 (2004) 2713-2718
    • (2004) Diabetes , vol.53 , pp. 2713-2718
    • Sagen, J.V.1    Raeder, H.2    Hathout, E.3    Shehadeh, N.4    Gudmundsson, K.5    Baevre, H.6
  • 71
    • 4644309915 scopus 로고    scopus 로고
    • Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients
    • Vaxillaire M., Populaire C., Busiah K., Cavé H., Gloyn A.L., Hattersley A.T., et al. Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 53 (2004) 2719-2722
    • (2004) Diabetes , vol.53 , pp. 2719-2722
    • Vaxillaire, M.1    Populaire, C.2    Busiah, K.3    Cavé, H.4    Gloyn, A.L.5    Hattersley, A.T.6
  • 74
    • 33746738864 scopus 로고    scopus 로고
    • Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
    • Tonini G., Bizzarri C., Bonfanti R., Vanelli M., Cerutti F., Faleschini E., et al. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia 49 (2006) 2210-2213
    • (2006) Diabetologia , vol.49 , pp. 2210-2213
    • Tonini, G.1    Bizzarri, C.2    Bonfanti, R.3    Vanelli, M.4    Cerutti, F.5    Faleschini, E.6
  • 75
    • 33846008028 scopus 로고    scopus 로고
    • Transfer to sulphonylurea therapy of adult subjects with permanent neonatal diabetes due to KCNJ11 activating mutations: evidence for improvement in insulin sensitivity
    • Malecki M.T., Skupien J., Klupa T., Wanic K., Mlynarski W., Gach A., et al. Transfer to sulphonylurea therapy of adult subjects with permanent neonatal diabetes due to KCNJ11 activating mutations: evidence for improvement in insulin sensitivity. Diabetes Care 30 (2007) 147-149
    • (2007) Diabetes Care , vol.30 , pp. 147-149
    • Malecki, M.T.1    Skupien, J.2    Klupa, T.3    Wanic, K.4    Mlynarski, W.5    Gach, A.6
  • 76
    • 8744262895 scopus 로고    scopus 로고
    • Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
    • Zung A., Glaser B., Nimri R., and Zadik Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J. Clin. Endocrinol. Metab. 89 (2004) 5504-5507
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 5504-5507
    • Zung, A.1    Glaser, B.2    Nimri, R.3    Zadik, Z.4
  • 77
    • 35748967277 scopus 로고    scopus 로고
    • Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11
    • Mlynarski W., Tarasov A.I., Gach A., Girard C.A., Pietrzak I., Zubcevic L., et al. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat. Clin. Pract. Neurol. 3 (2007) 640-645
    • (2007) Nat. Clin. Pract. Neurol. , vol.3 , pp. 640-645
    • Mlynarski, W.1    Tarasov, A.I.2    Gach, A.3    Girard, C.A.4    Pietrzak, I.5    Zubcevic, L.6
  • 78
    • 33744722778 scopus 로고    scopus 로고
    • A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes
    • Proks P., Arnold A.L., Bruining J., Girard C., Flanagan S.E., Larkin B., et al. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum. Mol. Genet. 15 (2006) 1793-1800
    • (2006) Hum. Mol. Genet. , vol.15 , pp. 1793-1800
    • Proks, P.1    Arnold, A.L.2    Bruining, J.3    Girard, C.4    Flanagan, S.E.5    Larkin, B.6
  • 79
    • 35148820198 scopus 로고    scopus 로고
    • Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period
    • Patch A.M., Flanagan S.E., Boustred C., Hattersley A.T., and Ellard S. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period. Diabetes Obes. Metab. 9 Suppl. 2 (2007) 28-39
    • (2007) Diabetes Obes. Metab. , vol.9 , Issue.SUPPL. 2 , pp. 28-39
    • Patch, A.M.1    Flanagan, S.E.2    Boustred, C.3    Hattersley, A.T.4    Ellard, S.5
  • 80
    • 34547747922 scopus 로고    scopus 로고
    • Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects
    • Ellard S., Flanagan S.E., Girard C.A., Patch A.M., Harries L.W., Parrish A., et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am. J. Hum. Genet. 81 (2007) 375-382
    • (2007) Am. J. Hum. Genet. , vol.81 , pp. 375-382
    • Ellard, S.1    Flanagan, S.E.2    Girard, C.A.3    Patch, A.M.4    Harries, L.W.5    Parrish, A.6
  • 81
    • 38949177444 scopus 로고    scopus 로고
    • Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations
    • Neonatal Diabetes International Collaborative Group
    • Rafiq M., Flanagan S.E., Patch A.M., Shields B.M., Ellard S., Hattersley A.T., and Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31 (2008) 204-209
    • (2008) Diabetes Care , vol.31 , pp. 204-209
    • Rafiq, M.1    Flanagan, S.E.2    Patch, A.M.3    Shields, B.M.4    Ellard, S.5    Hattersley, A.T.6
  • 82
    • 42449102605 scopus 로고    scopus 로고
    • Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group
    • Polak M., Dechaume A., Cavé H., Nimri R., Crosnier H., Sulmont V., et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes 57 (2008) 1115-1119
    • (2008) Diabetes , vol.57 , pp. 1115-1119
    • Polak, M.1    Dechaume, A.2    Cavé, H.3    Nimri, R.4    Crosnier, H.5    Sulmont, V.6
  • 83
    • 42449134450 scopus 로고    scopus 로고
    • Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood
    • Edghill E.L., Flanagan S.E., Patch A.M., Boustred C., Parrish A., Shields B., et al. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57 (2008) 1034-1042
    • (2008) Diabetes , vol.57 , pp. 1034-1042
    • Edghill, E.L.1    Flanagan, S.E.2    Patch, A.M.3    Boustred, C.4    Parrish, A.5    Shields, B.6
  • 84
    • 0036797965 scopus 로고    scopus 로고
    • Neonatal diabetes mellitus: neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases
    • Metz C., Cave H., Bertrand A.M., Deffert C., Gueguen-Giroux B., Czernichow P., et al. Neonatal diabetes mellitus: neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J. Pediatr. 141 (2002) 483-489
    • (2002) J. Pediatr. , vol.141 , pp. 483-489
    • Metz, C.1    Cave, H.2    Bertrand, A.M.3    Deffert, C.4    Gueguen-Giroux, B.5    Czernichow, P.6
  • 85
    • 0035167967 scopus 로고    scopus 로고
    • The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
    • Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27 (2001) 20-21
    • (2001) Nat. Genet. , vol.27 , pp. 20-21
    • Bennett, C.L.1    Christie, J.2    Ramsdell, F.3    Brunkow, M.E.4    Ferguson, P.J.5    Whitesell, L.6
  • 86
    • 23944510233 scopus 로고    scopus 로고
    • Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)
    • Bindl L., Torgerson T., Perroni L., Youssef N., Ochs H.D., Goulet O., et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J. Pediatr. 47 (2005) 256-259
    • (2005) J. Pediatr. , vol.47 , pp. 256-259
    • Bindl, L.1    Torgerson, T.2    Perroni, L.3    Youssef, N.4    Ochs, H.D.5    Goulet, O.6
  • 87
    • 42949167333 scopus 로고    scopus 로고
    • Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome
    • Zhan H., Sinclair J., Adams S., Cale C.M., Murch S., Perroni L., et al. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Pediatrics 121 (2008) e998-e1002
    • (2008) Pediatrics , vol.121
    • Zhan, H.1    Sinclair, J.2    Adams, S.3    Cale, C.M.4    Murch, S.5    Perroni, L.6
  • 89
    • 27844525503 scopus 로고    scopus 로고
    • Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure
    • Porter J.R., and Barrett T.G. Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure. J. Med. Genet. 42 (2005) 893-902
    • (2005) J. Med. Genet. , vol.42 , pp. 893-902
    • Porter, J.R.1    Barrett, T.G.2
  • 90
    • 0026578917 scopus 로고
    • Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans
    • Accili D., Barbetti F., Cama A., Kadowaki H., Kadowaki T., Imano E., et al. Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans. J. Invest. Dermatol. 89 (1992) 77S-81S
    • (1992) J. Invest. Dermatol. , vol.89
    • Accili, D.1    Barbetti, F.2    Cama, A.3    Kadowaki, H.4    Kadowaki, T.5    Imano, E.6
  • 93
    • 0027245458 scopus 로고
    • Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes
    • Kuzuya H., Matsuura N., Sakamoto M., Makino H., Sakamoto Y., Kadowaki T., et al. Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42 (1993) 696-705
    • (1993) Diabetes , vol.42 , pp. 696-705
    • Kuzuya, H.1    Matsuura, N.2    Sakamoto, M.3    Makino, H.4    Sakamoto, Y.5    Kadowaki, T.6
  • 94
    • 0031733512 scopus 로고    scopus 로고
    • Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism
    • Nakae J., Kato M., Murashita M., Shinohara N., Tajima T., and Fujieda K. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. J. Clin. Endocrinol. Metab. 83 (1998) 542-549
    • (1998) J. Clin. Endocrinol. Metab. , vol.83 , pp. 542-549
    • Nakae, J.1    Kato, M.2    Murashita, M.3    Shinohara, N.4    Tajima, T.5    Fujieda, K.6
  • 97
    • 0034941121 scopus 로고    scopus 로고
    • Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
    • Magre J., Delepine M., Khallouf E., Gedde-Dahl Jr. T., Van Maldergem L., Sobel E., et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28 (2001) 365-370
    • (2001) Nat. Genet. , vol.28 , pp. 365-370
    • Magre, J.1    Delepine, M.2    Khallouf, E.3    Gedde-Dahl Jr., T.4    Van Maldergem, L.5    Sobel, E.6
  • 98
    • 0034059075 scopus 로고    scopus 로고
    • Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
    • Cao H., and Hegele R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9 (2000) 109-112
    • (2000) Hum. Mol. Genet. , vol.9 , pp. 109-112
    • Cao, H.1    Hegele, R.A.2
  • 99
    • 0034074434 scopus 로고    scopus 로고
    • Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes
    • Hegele R.A., Anderson C.M., Wang J., Jones D.C., and Cao H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10 (2000) 652-658
    • (2000) Genome Res. , vol.10 , pp. 652-658
    • Hegele, R.A.1    Anderson, C.M.2    Wang, J.3    Jones, D.C.4    Cao, H.5
  • 101
    • 0033599038 scopus 로고    scopus 로고
    • Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
    • Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999) 880-883
    • (1999) Nature , vol.402 , pp. 880-883
    • Barroso, I.1    Gurnell, M.2    Crowley, V.E.3    Agostini, M.4    Schwabe, J.W.5    Soos, M.A.6
  • 102
    • 0036894397 scopus 로고    scopus 로고
    • PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy
    • Hegele R.A., Cao H., Frankowski C., Mathews S.T., and Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51 (2002) 3586-3590
    • (2002) Diabetes , vol.51 , pp. 3586-3590
    • Hegele, R.A.1    Cao, H.2    Frankowski, C.3    Mathews, S.T.4    Leff, T.5
  • 103
    • 0344375097 scopus 로고    scopus 로고
    • Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma
    • Savage D.B., Tan G.D., Acerini C.L., Jebb S.A., Agostini M., Gurnell M., et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52 (2003) 910-917
    • (2003) Diabetes , vol.52 , pp. 910-917
    • Savage, D.B.1    Tan, G.D.2    Acerini, C.L.3    Jebb, S.A.4    Agostini, M.5    Gurnell, M.6
  • 104
    • 12144291700 scopus 로고    scopus 로고
    • Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma
    • Agostini M., Gurnell M., Savage D.B., Wood E.M., Smith A.G., Rajanayagam O., et al. Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. Endocrinology 145 (2004) 1527-1538
    • (2004) Endocrinology , vol.145 , pp. 1527-1538
    • Agostini, M.1    Gurnell, M.2    Savage, D.B.3    Wood, E.M.4    Smith, A.G.5    Rajanayagam, O.6
  • 105
    • 2542528670 scopus 로고    scopus 로고
    • A family with severe insulin resistance and diabetes due to a mutation in AKT2
    • George S., Rochford J.J., Wolfrum C., Gray S.L., Schinner S., Wilson J.C., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304 (2004) 1325-1328
    • (2004) Science , vol.304 , pp. 1325-1328
    • George, S.1    Rochford, J.J.2    Wolfrum, C.3    Gray, S.L.4    Schinner, S.5    Wilson, J.C.6
  • 108
    • 14844295735 scopus 로고    scopus 로고
    • Lessons from human mutations in PPARgamma
    • Hegele R.A. Lessons from human mutations in PPARgamma. Int. J. Obes. (Lond.) 29 Suppl. 1 (2005) S31-S35
    • (2005) Int. J. Obes. (Lond.) , vol.29 , Issue.SUPPL. 1
    • Hegele, R.A.1
  • 110
    • 0642312212 scopus 로고    scopus 로고
    • Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
    • Owen K.R., Donohoe M., Ellard S., and Hattersley A.T. Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene. Diabet. Med. 20 (2003) 823-827
    • (2003) Diabet. Med. , vol.20 , pp. 823-827
    • Owen, K.R.1    Donohoe, M.2    Ellard, S.3    Hattersley, A.T.4
  • 112
    • 0032961820 scopus 로고    scopus 로고
    • The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus
    • Shaw J.T., Purdie D.M., Neil H.A., Levy J.C., and Turner R.C. The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus. Diabetologia 42 (1999) 24-27
    • (1999) Diabetologia , vol.42 , pp. 24-27
    • Shaw, J.T.1    Purdie, D.M.2    Neil, H.A.3    Levy, J.C.4    Turner, R.C.5
  • 113
    • 0035557623 scopus 로고    scopus 로고
    • Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes
    • McCarthy M.I., and Hattersley A.T. Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev. Mol. Diagn. 4 (2001) 403-412
    • (2001) Expert Rev. Mol. Diagn. , vol.4 , pp. 403-412
    • McCarthy, M.I.1    Hattersley, A.T.2
  • 114
    • 34249885875 scopus 로고    scopus 로고
    • A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
    • Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
    • (2007) Science , vol.316 , pp. 1341-1345
    • Scott, L.J.1    Mohlke, K.L.2    Bonnycastle, L.L.3    Willer, C.J.4    Li, Y.5    Duren, W.L.6
  • 115
    • 34249888775 scopus 로고    scopus 로고
    • Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
    • Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research
    • Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
    • (2007) Science , vol.316 , pp. 1331-1336
    • Voight, B.F.1    Lyssenko, V.2    Burtt, N.P.3    de Bakker, P.I.4    Chen, H.5    Saxena, R.6
  • 116
    • 34249895023 scopus 로고    scopus 로고
    • Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
    • Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
    • (2007) Science , vol.316 , pp. 1336-1341
    • Zeggini, E.1    Weedon, M.N.2    Lindgren, C.M.3    Frayling, T.M.4    Elliott, K.S.5    Lango, H.6
  • 117
    • 34547585382 scopus 로고    scopus 로고
    • Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study
    • Pearson E.R., Donnelly L.A., Kimber C., Whitley A., Doney A.S., McCarthy M.I., et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 56 (2007) 2178-2182
    • (2007) Diabetes , vol.56 , pp. 2178-2182
    • Pearson, E.R.1    Donnelly, L.A.2    Kimber, C.3    Whitley, A.4    Doney, A.S.5    McCarthy, M.I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.